Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.

Chirurgia italiana - 1 Jan 2000

Cherubini Mariano, Baxa Pietro, Guarino Gerardo

Abstract excerpt

Two groups of patients were chosen from among 4,025 subjects examined in a breast screening program, one consisting of patients with stage I and the other of patients with stage IV breast cancer, characterized by neoplastic recurrence. In this comparison p53, HER and grading are of no direct help. We investigated receptor status at the time of the first operation and after complete surgical excision of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Data Interpretation, Statistical
Share to Lymph Node Excision

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastectomy

Share to Neoplasm Recurrence, Local

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Survival Analysis

Source

Identifiers

PMID: 12239750

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.PMID 12239750Read ↗

Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.Semantic proximity Read ↗

Molecular characterisation of breast cancer patients at high and low recurrence risk.Semantic proximity Read ↗

[Temporary dependency of steroid-receptor prognostic value in breast cancer].Semantic proximity Read ↗

Oestrogen receptor: a stable phenotype in breast cancer.Semantic proximity Read ↗

Estrogen and progesterone receptor expression in the mammary gland tumors.Semantic proximity Read ↗

Detection of p53 auto-antibodies in the sera of breast cancer patients with a new recurrence using an ELISA assay. Does a correlation with the recurrence free interval exist?Semantic proximity Read ↗

Immunohistochemical analysis of the functional status of estrogen receptor cascade in breast cancer.Semantic proximity Read ↗

Circulating estradiol defines the tumor phenotype in menopausal breast cancer patients.Semantic proximity Read ↗

Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women.Semantic proximity Read ↗

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.Semantic proximity Read ↗

Comparative study of the immunohistochemical phenotype in breast cancer and its lymph node metastatic location.Semantic proximity Read ↗

Anti-apoptotic phenotype is associated with decreased locoregional recurrence rate in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.